Langer CJ - Search Results

1

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

Hirsch FR, Kerr KM, Bunn PA Jr, Kim ES, Obasaju C, Pérol M, Bonomi P, Bradley JD, Gandara D, Jett JR, Langer CJ, Natale RB, Novello S, Paz-Ares L, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Stinchcombe TE, Vansteenkiste JF, Wakelee H, Thatcher N. Hirsch FR, et al. Among authors: langer cj. Clin Lung Cancer. 2018 Jul;19(4):331-339. doi: 10.1016/j.cllc.2018.03.014. Epub 2018 Mar 21. Clin Lung Cancer. 2018. PMID: 29773328 Free article. Review.

2

Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.

Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL. Langer CJ, et al. Cancer J Sci Am. 1996 Mar-Apr;2(2):99-105. Cancer J Sci Am. 1996. PMID: 9166507 Clinical Trial.

3

An update on North American randomized studies in non-small cell lung cancer.

Bunn PA Jr, Vokes EE, Langer CJ, Schiller JH. Bunn PA Jr, et al. Among authors: langer cj. Semin Oncol. 1998 Aug;25(4 Suppl 9):2-10. Semin Oncol. 1998. PMID: 9728578 Review.

4

Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.

Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Langer CJ, et al. Semin Oncol. 1999 Feb;26(1 Suppl 4):12-8. Semin Oncol. 1999. PMID: 10201516 Review.

5

Induction or neoadjuvant therapy in resectable non-small cell lung cancer.

Langer CJ. Langer CJ. Semin Oncol. 1999 Oct;26(5 Suppl 15):34-9. Semin Oncol. 1999. PMID: 10566609 Review.

6

Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.

Socinski MA, Langer CJ. Socinski MA, et al. Among authors: langer cj. Semin Oncol. 1999 Oct;26(5 Suppl 16):51-61; discussion 71-2. Semin Oncol. 1999. PMID: 10585009 Review.

7

Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.

Schilder RJ, Goldberg M, Millenson MM, Movsas B, Rogatko A, Rogers B, Langer CJ. Schilder RJ, et al. Among authors: langer cj. Lung Cancer. 2000 Jan;27(1):37-45. doi: 10.1016/s0169-5002(99)00091-4. Lung Cancer. 2000. PMID: 10672782 Clinical Trial.

8

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Jagasia MH, et al. Among authors: langer cj. Clin Cancer Res. 2001 Jan;7(1):68-73. Clin Cancer Res. 2001. PMID: 11205920 Clinical Trial.

9

The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer.

Langer CJ. Langer CJ. Lung Cancer. 2001 Nov;34(2):297-303. doi: 10.1016/s0169-5002(01)00258-6. Lung Cancer. 2001. PMID: 11679189 Review.

10

Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma.

Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH. Sweeney CJ, et al. Among authors: langer c. Cancer. 2001 Nov 15;92(10):2639-47. doi: 10.1002/1097-0142(20011115)92:10<2639::aid-cncr1617>3.0.co;2-8. Cancer. 2001. PMID: 11745199 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page